Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use

Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use

US Patent 10576141 · Granted Mar 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapy for treating cancer with an intratumoral or intravenous administration o2025
Methods and compositions for inducing protective immunity against filovirus infe2024
Methods and compositions for inducing protective immunity against filovirus infe2024
Methods and compositions for inducing protective immunity against filovirus infe2024
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Compositions and methods for enhancing the stability of transgenes in poxviruses2023
Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vacci2023
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022